Viewing Study NCT00911261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-24 @ 11:58 PM
Study NCT ID: NCT00911261
Status: COMPLETED
Last Update Posted: 2010-02-15
First Post: 2009-05-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
Sponsor: Endo Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Pain View
None Neuropathic Pain View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer Pain View
None Neuropathic Pain View
None Extended Release View
None Long-Acting Opioid View
None Oxymorphone View